Xiaochang Gong

519 East Beijing Road
Nanchang, 330029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Overlap-adapted Subvolume Prescription to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study with a Contemporaneous Comparator.

Overlap-adapted Subvolume Prescription to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study with a Contemporaneous Comparator.

Journal: Practical radiation oncology

Published: April 27, 2026

Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy.

Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy.

Journal: Frontiers in oncology

Published: August 28, 2025

Bacterial Decolonization With Mupirocin Ointment for Acute Radiation Oral Mucositis Prevention: A Phase 3 Randomized Clinical Trial.

Bacterial Decolonization With Mupirocin Ointment for Acute Radiation Oral Mucositis Prevention: A Phase 3 Randomized Clinical Trial.

Journal: JAMA oncology

Published: August 07, 2025

Effects of Nutritional Interventions on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiation Therapy Based on Dynamic Nutritional Risk Screening and Assessment: An Open-Label Single-Center Randomized Phase 3 Trial.

Effects of Nutritional Interventions on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiation Therapy Based on Dynamic Nutritional Risk Screening and Assessment: An Open-Label Single-Center Randomized Phase 3 Trial.

Journal: International journal of radiation oncology, biology, physics

Published: May 04, 2025

Development and validation of a machine learning-based model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma.

Development and validation of a machine learning-based model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma.

Journal: Radiation oncology (London, England)

Published: March 31, 2025

Oral dose-volume parameters as independent predictors of severe radiation-induced mucositis in nasopharyngeal carcinoma patients: a retrospective study.

Oral dose-volume parameters as independent predictors of severe radiation-induced mucositis in nasopharyngeal carcinoma patients: a retrospective study.

Journal: American journal of translational research

Published: February 06, 2025

Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma.

Prognostic Significance of Circulating Immune Subset Counts in Nasopharyngeal Carcinoma.

Journal: ImmunoTargets and therapy

Published: January 15, 2025

Integrated Early CRP Kinetics and Plasma EBV DNA Clearance as Prognostic Biomarkers in De Novo Metastatic Nasopharyngeal Carcinoma Treated with First-Line Chemoimmunotherapy.

Integrated Early CRP Kinetics and Plasma EBV DNA Clearance as Prognostic Biomarkers in De Novo Metastatic Nasopharyngeal Carcinoma Treated with First-Line Chemoimmunotherapy.

Journal: Journal of inflammation research

Published: January 12, 2025

Infiltrating B-cell subtypes and associated hub genes in nasopharyngeal carcinoma identified from integrated single-cell, bulk RNA-sequencing, and immunohistochemical data.

Infiltrating B-cell subtypes and associated hub genes in nasopharyngeal carcinoma identified from integrated single-cell, bulk RNA-sequencing, and immunohistochemical data.

Journal: Hereditas

Published: December 23, 2024

HMMR mediates progression of nasopharyngeal carcinoma by inhibiting FAM83D ubiquitination and activating beta-catenin signaling pathway.

HMMR mediates progression of nasopharyngeal carcinoma by inhibiting FAM83D ubiquitination and activating beta-catenin signaling pathway.

Journal: Scientific reports

Published: December 21, 2024

Validation and development of a refined M1 category for nasopharyngeal carcinoma based on the version-nine of AJCC/UICC TNM staging system in the immunotherapy era: A multicenter cohort study.

Validation and development of a refined M1 category for nasopharyngeal carcinoma based on the version-nine of AJCC/UICC TNM staging system in the immunotherapy era: A multicenter cohort study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 14, 2024

Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study.

Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study.

Journal: International journal of cancer

Published: September 20, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026